1 |
Galinsky AM. Composition and method for making a suppository for introducing a hypoglycemic agent into a mammal. US Patent 4164573, 1979
|
2 |
Wang H, Li Y, Sun Q et al. Oral administration of insulin to female nonobese diabetic mice inhibited diabetes and induced Fas ligand expression on islets of Langerhans. Chin Med J (Engl), 113(5):433-436, 2000
|
3 |
Radwan MA. Enhancement of absorption of insulin loaded polyisobutylcyanoacrylate nanospheres by sodium cholate after oral and subcutaneous administration in diabetic rats. Drug Dev Ind Pharm, 27(9):981-989, 2001
|
4 |
Murthy KS, Kubert DA, Fawzi MB. In vitro release characteristics of hard shell capsule products coated with aqueous- and organic-based enteric polymers. J Biomater Appl, 3(1):52-79, 1988
|
5 |
Longenecker JP, Moses AC, Flier JS et al. Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep. J Pharm Sci, 76(5):351-355, 1987
|
6 |
Thomson AB, Kirdeikis P, Lastiwka R et al. Pharmacokinetics and pharmacodynamics during treatment with the omeprazole 20 mg enteric-coated tablet and 20 mg capsule in asymptomatic duodenal ulcer patients. Can J Gastroenterol, 11(8):657-660, 1997
|
7 |
Fernandez-Moreno MD, Serrano-Rios M, Prieto JC. Identification of insulin receptors in epithelial cells from duodenum, jejunum, ileum, caecum, colon and rectum in the rat Diabete Metab, 13(2):135-139, 1987
|
8 |
Heinemann L, Pfutzner A, Heise T. Alternative routes of administration as an approach to improve insulin therapy: update on dermal, oral, nasal and pulmonary insulin delivery. Curr Pharm Des, 7(14):1327-51, 2001
|
9 |
Kidron M, Ziv E, Bar-On H et al. Pharmaceutical compositions containing insulin. US Patent 4579730, 1986
|
10 |
Bai JP, Chang LL, Guo JH. Effects of polyacrylic polymers on the degradation of insulin and peptide drugs by chymotrypsin and trypsin. J Pharm Pharmacol, 48(1):17-21, 1996
|
11 |
Charman SA, McLennan DN, Edwards GA et al. Lymphatic absorption is a significant contributor to the subcutaneous bioavailability of insulin in a sheep model. Pharm Res, 18(11):1620-6, 2001
|
12 |
Tokihiro K, Arima H, Tajiri S et al. Improvement of subcutaneous bioavailability of insulin by sulphobutylether beta-cyclodextrin in rats. J Pharm Pharmacol, 52(8):911-7, 2000
|
13 |
Ishida M, Machida Y, Nambu N et al. New mucosal dosage form of insulin. Chem Pharm Bull, 29:810-816, 1981
|
14 |
Foster TP. Protein/peptide veterinary formulations. In: Development and formulation of veterinary dasage forms, 2nd ed. New York: Marcel Dekker, 231-282, 1998
|
15 |
Levitan DM. Transplantation for the treatment of diabetes mellitus. Semin Vet Med Surg (Small Anim), 12(4):268-273, 1997
|